✦ LIBER ✦

Analysis of the risk factors for myelosuppression after concurrent chemoradiotherapy for patients with advanced non-small cell lung cancer

✍ Scribed by Nan Jiang, Xiao-Cen Chen, Yue Zhao

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical analysis of concurrent chemorad

✍ Zhihua Sun; Qinfeng Li; Zhenyu Li; Yeshan Chen; Yao Jiang; Gang Wu 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 259 KB

Risk Associated with Bilobectomy after N

✍ Jong Ho Cho; Jhingook Kim; Kwhanmien Kim; Young Mog Shim; Hong Kwan Kim; Yong So 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 424 KB

Factors affecting survival time after re

✍ Yasushi Hamamoto; Masaaki Kataoka; Naoyuki Nogami; Toshiyuki Kozuki; Yuka Kato; 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 286 KB

Concurrent Chemoradiotherapy for Locally

✍ J. Helbrow; F. MacNicoll; N. Bayman; C. Faivre-Finn 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Concurrent chemoradiotherapy in locally

✍ Zemanová, Milada; Honová, Hana; Havel, Libor; Homolka, Jiří; Petruželka, Luboš 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Factors Affect the Survival Time after R

✍ Hamamoto, Y.; Kataoka, M.; Semba, T.; Uwatsu, K.; Sugawara, Y.; Inoue, T.; Sakai 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 38 KB